Add to ORKGThis article has not been copye ited and formatted. The final version may differ from this version
Substance use disorder is characterized by repeated use of a substance, leading to clinically signif...
Selective modulation of peripheral cannabinoid receptors (CBRs) has potential therapeutic applicatio...
Although a variety of drugs are available for the treatment of depression, therapy is not effective ...
This review examines the development of cannabinoid CB1 receptor antagonists as a new class of thera...
The CB1 and CB2 cannabinoid receptors have been described as two prime sites of action for endocanna...
This article has not been copyedited and for atted. The final version may differ from this version
Anti-obesity efficacy of a novel cannabinoid-1 receptor inverse agonist MK-0364 in rodent
Michael B Steinberg1,2, Jonathan Foulds11University of Medicine and Dentistry of New Jersey–Sc...
Prolonged exposure to drugs of abuse leads to severe alterations in mesocorticolimbic dopamine circu...
Prolonged exposure to drugs of abuse leads to severe alterations in mesocorticolimbic dopamine circu...
Abstract: Since the discovery of an endogenous cannabinoid system, research into the pharmacology an...
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted, cannabino...
This review covers the progress made in the field of CB1 and CB2 cannabinoid receptor antagonists an...
Substance use disorder is characterized by repeated use of a substance, leading to clinically signif...
Title: The genetic versus pharmacological invalidation of the cannabionoid CB1 receptor results in ...
Substance use disorder is characterized by repeated use of a substance, leading to clinically signif...
Selective modulation of peripheral cannabinoid receptors (CBRs) has potential therapeutic applicatio...
Although a variety of drugs are available for the treatment of depression, therapy is not effective ...
This review examines the development of cannabinoid CB1 receptor antagonists as a new class of thera...
The CB1 and CB2 cannabinoid receptors have been described as two prime sites of action for endocanna...
This article has not been copyedited and for atted. The final version may differ from this version
Anti-obesity efficacy of a novel cannabinoid-1 receptor inverse agonist MK-0364 in rodent
Michael B Steinberg1,2, Jonathan Foulds11University of Medicine and Dentistry of New Jersey–Sc...
Prolonged exposure to drugs of abuse leads to severe alterations in mesocorticolimbic dopamine circu...
Prolonged exposure to drugs of abuse leads to severe alterations in mesocorticolimbic dopamine circu...
Abstract: Since the discovery of an endogenous cannabinoid system, research into the pharmacology an...
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted, cannabino...
This review covers the progress made in the field of CB1 and CB2 cannabinoid receptor antagonists an...
Substance use disorder is characterized by repeated use of a substance, leading to clinically signif...
Title: The genetic versus pharmacological invalidation of the cannabionoid CB1 receptor results in ...
Substance use disorder is characterized by repeated use of a substance, leading to clinically signif...
Selective modulation of peripheral cannabinoid receptors (CBRs) has potential therapeutic applicatio...
Although a variety of drugs are available for the treatment of depression, therapy is not effective ...